List of Tables
Table 1. Global Rifaximin API Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Rifaximin API Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Rifaximin API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rifaximin API Sales (Kiloton) of Key Manufacturers (2018-2023)
Table 5. Global Rifaximin API Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Rifaximin API Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Rifaximin API Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Rifaximin API Average Price (US$/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Rifaximin API, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Rifaximin API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rifaximin API, Product Type & Application
Table 12. Global Key Manufacturers of Rifaximin API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rifaximin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifaximin API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rifaximin API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Rifaximin API Sales by Region (2018-2023) & (Kiloton)
Table 18. Global Rifaximin API Sales Market Share by Region (2018-2023)
Table 19. Global Rifaximin API Sales by Region (2024-2029) & (Kiloton)
Table 20. Global Rifaximin API Sales Market Share by Region (2024-2029)
Table 21. Global Rifaximin API Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Rifaximin API Revenue Market Share by Region (2018-2023)
Table 23. Global Rifaximin API Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Rifaximin API Revenue Market Share by Region (2024-2029)
Table 25. North America Rifaximin API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Rifaximin API Sales by Country (2018-2023) & (Kiloton)
Table 27. North America Rifaximin API Sales by Country (2024-2029) & (Kiloton)
Table 28. North America Rifaximin API Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Rifaximin API Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Rifaximin API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Rifaximin API Sales by Country (2018-2023) & (Kiloton)
Table 32. Europe Rifaximin API Sales by Country (2024-2029) & (Kiloton)
Table 33. Europe Rifaximin API Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Rifaximin API Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Rifaximin API Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Rifaximin API Sales by Region (2018-2023) & (Kiloton)
Table 37. Asia Pacific Rifaximin API Sales by Region (2024-2029) & (Kiloton)
Table 38. Asia Pacific Rifaximin API Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Rifaximin API Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Rifaximin API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Rifaximin API Sales by Country (2018-2023) & (Kiloton)
Table 42. Latin America Rifaximin API Sales by Country (2024-2029) & (Kiloton)
Table 43. Latin America Rifaximin API Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Rifaximin API Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rifaximin API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Rifaximin API Sales by Country (2018-2023) & (Kiloton)
Table 47. Middle East & Africa Rifaximin API Sales by Country (2024-2029) & (Kiloton)
Table 48. Middle East & Africa Rifaximin API Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rifaximin API Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Rifaximin API Sales (Kiloton) by Type (2018-2023)
Table 51. Global Rifaximin API Sales (Kiloton) by Type (2024-2029)
Table 52. Global Rifaximin API Sales Market Share by Type (2018-2023)
Table 53. Global Rifaximin API Sales Market Share by Type (2024-2029)
Table 54. Global Rifaximin API Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Rifaximin API Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Rifaximin API Revenue Market Share by Type (2018-2023)
Table 57. Global Rifaximin API Revenue Market Share by Type (2024-2029)
Table 58. Global Rifaximin API Price (US$/Ton) by Type (2018-2023)
Table 59. Global Rifaximin API Price (US$/Ton) by Type (2024-2029)
Table 60. Global Rifaximin API Sales (Kiloton) by Application (2018-2023)
Table 61. Global Rifaximin API Sales (Kiloton) by Application (2024-2029)
Table 62. Global Rifaximin API Sales Market Share by Application (2018-2023)
Table 63. Global Rifaximin API Sales Market Share by Application (2024-2029)
Table 64. Global Rifaximin API Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Rifaximin API Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Rifaximin API Revenue Market Share by Application (2018-2023)
Table 67. Global Rifaximin API Revenue Market Share by Application (2024-2029)
Table 68. Global Rifaximin API Price (US$/Ton) by Application (2018-2023)
Table 69. Global Rifaximin API Price (US$/Ton) by Application (2024-2029)
Table 70. Salix Pharmaceuticals Corporation Information
Table 71. Salix Pharmaceuticals Description and Business Overview
Table 72. Salix Pharmaceuticals Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 73. Salix Pharmaceuticals Rifaximin API Product
Table 74. Salix Pharmaceuticals Recent Developments/Updates
Table 75. Lupin Corporation Information
Table 76. Lupin Description and Business Overview
Table 77. Lupin Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 78. Lupin Rifaximin API Product
Table 79. Lupin Recent Developments/Updates
Table 80. LGM Pharma Corporation Information
Table 81. LGM Pharma Description and Business Overview
Table 82. LGM Pharma Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. LGM Pharma Rifaximin API Product
Table 84. LGM Pharma Recent Developments/Updates
Table 85. B Joshi Agrochem Pharma Corporation Information
Table 86. B Joshi Agrochem Pharma Description and Business Overview
Table 87. B Joshi Agrochem Pharma Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. B Joshi Agrochem Pharma Rifaximin API Product
Table 89. B Joshi Agrochem Pharma Recent Developments/Updates
Table 90. Triveni Interchem Corporation Information
Table 91. Triveni Interchem Description and Business Overview
Table 92. Triveni Interchem Rifaximin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. Triveni Interchem Rifaximin API Product
Table 94. Triveni Interchem Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Rifaximin API Distributors List
Table 98. Rifaximin API Customers List
Table 99. Rifaximin API Market Trends
Table 100. Rifaximin API Market Drivers
Table 101. Rifaximin API Market Challenges
Table 102. Rifaximin API Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rifaximin API
Figure 2. Global Rifaximin API Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Rifaximin API Market Share by Type in 2022 & 2029
Figure 4. 99% Purity Product Picture
Figure 5. >99% Purity Product Picture
Figure 6. Global Rifaximin API Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Rifaximin API Market Share by Application in 2022 & 2029
Figure 8. Pharmaceuticals
Figure 9. Others
Figure 10. Global Rifaximin API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Rifaximin API Market Size (2018-2029) & (US$ Million)
Figure 12. Global Rifaximin API Sales (2018-2029) & (Kiloton)
Figure 13. Global Rifaximin API Average Price (US$/Ton) & (2018-2029)
Figure 14. Rifaximin API Report Years Considered
Figure 15. Rifaximin API Sales Share by Manufacturers in 2022
Figure 16. Global Rifaximin API Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Rifaximin API Players: Market Share by Revenue in 2022
Figure 18. Rifaximin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Rifaximin API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Rifaximin API Sales Market Share by Country (2018-2029)
Figure 21. North America Rifaximin API Revenue Market Share by Country (2018-2029)
Figure 22. United States Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Rifaximin API Sales Market Share by Country (2018-2029)
Figure 25. Europe Rifaximin API Revenue Market Share by Country (2018-2029)
Figure 26. Germany Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Rifaximin API Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Rifaximin API Revenue Market Share by Region (2018-2029)
Figure 33. China Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Rifaximin API Sales Market Share by Country (2018-2029)
Figure 43. Latin America Rifaximin API Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Rifaximin API Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Rifaximin API Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Rifaximin API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Rifaximin API by Type (2018-2029)
Figure 53. Global Revenue Market Share of Rifaximin API by Type (2018-2029)
Figure 54. Global Rifaximin API Price (US$/Ton) by Type (2018-2029)
Figure 55. Global Sales Market Share of Rifaximin API by Application (2018-2029)
Figure 56. Global Revenue Market Share of Rifaximin API by Application (2018-2029)
Figure 57. Global Rifaximin API Price (US$/Ton) by Application (2018-2029)
Figure 58. Rifaximin API Value Chain
Figure 59. Rifaximin API Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed